Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Influenza Vaccine Trial

疫苗和治疗评估单位：第一阶段流感疫苗试验的方案制定和实施

• 批准号: 9935239
• 负责人: DANIEL HOFT
• 金额: $ 63.18万
• 依托单位: SAINT LOUIS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-10-15 至 2019-04-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9935239
• 关键词: Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Influenza; Phase; Population; Resources; Vaccines; combat; design; influenza virus vaccine; named group; programs; protocol development; vaccine trial

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同组成，为临床试验的设计和进行提供现成的资源，以评估有前途的产品来对抗传染病。一般来说，产品将在正常健康人群中进行评估;但是，也可以接触特殊人群。